Market Research Size

Wednesday, 3 February 2021

Wearable Medical Devices Market to Expand at a CAGR of 26.8% Through 2028

Wearable Medical Devices Market Growth & Trends

The global wearable medical devices market size is expected to reach USD 111.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 26.8% from 2021 to 2028. Rising demand for hi-tech products and continuous health monitoring is fueling market growth.

Increasing obesity rate coupled with rising awareness about physical fitness is encouraging people to go for workouts and adopt other fitness-related activities. Wearable devices such as smart bands and smartwatches help in monitoring fitness parameters consisting of calories burned, footstep count, heart rate and distance covered. Moreover, these wearable devices companies offer guidance from experts who are certified dietician or nutrition, and hence, this business model is also generating hefty demand for these ancillary products and services.

Companies such as Google, Fitbit, Apple, and Nike are working towards the launch of new innovative products that are anticipated to boost market growth over the forecast period, thus portraying a high growth rate. Smart watches and wristbands are the current focal point of product development and innovation, leading to abundant availability of such instruments. For instance, HealthPatch, a product of Vital Connect, was launched in March 2014. The product is an adhesive patch that can be placed anywhere on the chest and is used to regulate biometrics such as heart rate, skin temperature, body posture, and activities like steps walked.

The COVID-19 pandemic somehow has a positive impact on the market owing to increasing demand for telemedicine. As per the WHO guidelines people should follow social distancing and avoid public gathering. Hence due to this reason various physicians are preferring telemedicine route so that they can treat patients from distance without spreading the virus. Growth of telemedicine and expansion of applications to Integrate artificial intelligence (AI) in its systems has led to market growth.

Request a free sample copy or view report summary: Wearable Medical Devices Market Report

Wearable Medical Devices Market Report Highlights

The diagnostic devices segment dominated the market in 2020 owing to the increasing disposable income and awareness, and higher healthcare spending
The strap/clip/bracelet segment dominated the market in 2020 and is expected to continue its dominance over the forecast period
Home healthcare held a significant share of 54.0% in 2020 owing to the growing base of geriatric population triggering incidence rates of target diseases
North America is projected to command for a cumulative share in 2020 due to the increasing application of home care and remote patient monitoring for the purpose of regular, continuous, and long-term monitoring of patients
Asia Pacific is expected to witness the fastest growth rate over the forecast period. This growth can be attributed to the growing awareness level, increasing disposable income, presence of a large population base and rising incidence rate of chronic conditions

Wearable Medical Devices Market Segmentation

Grand View Research has segmented the global wearable medical devices market based on product, site, application, and region:

Wearable Medical Devices Product Outlook (Revenue, USD Billion, 2016 - 2028)

Diagnostic Devices
- Vital Sign Monitoring Devices
  - Heart Rate Monitors
  - Activity Monitors
  - Electrocardiographs
  - Pulse Oximeters
  - Spirometers
  - Blood Pressure Monitors
  - Others
- Sleep Monitoring Devices
  - Sleep trackers
  - Wrist Actigraphs
  - Polysomnographs
  - Others
- Electrocardiographs Fetal And Obstetric Devices
- Neuromonitoring Devices
  - Electroencephalographs
  - Electromyographs
  - Others
- Therapeutic Devices
  - Pain Management
    - Neurostimulation
    - Others
  - Insulin/Glucose Monitoring
    - Insulin Pumps
    - Others
  - Rehabilitation
    - Accelometers
    - Sensing
    - Ultrasound Platform
    - Others
  - Respiratory Therapy
    - Ventilators
    - Positive Airway Pressure (PAP) Devices
    - Portable Oxygen Concentrators
    - Others

Wearable Medical Devices Site Outlook (Revenue, USD Billion, 2016 - 2028)

Handheld
Headband
Strap/Clip/Bracelet
Shoe Sensors
Others

Wearable Medical Devices Application Outlook (Revenue, USD Billion, 2016 - 2028)

Sports And Fitness
Remote Patient Monitoring
Home Healthcare

Wearable Medical Devices Regional Outlook (Revenue, USD Billion, 2016 - 2028)

North America
- US.
- Canada
Europe
- France
- Germany
- UK.
- Italy
- Spain
- Sweden
- Russia
- Netherlands
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Thailand
- Philippines
- Malaysia
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE

List of Key Players of Wearable Medical Devices Market

Philips Electronics
Fitbit
Basis Science
Garmin
Covidien
Omron Corp.
Withings
Vital Connect
Polar Electro
Intelesens
Everist Genomics
Intelesens
Sotera Wireless

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 1 February 2021

Non-invasive Prenatal Testing Market Outlook, Leading Manufacturers, Industry Analysis And Forecast

Non-invasive Prenatal Testing Market Growth & Trends

The global non invasive prenatal testing market size is anticipated to reach USD 6.5 billion by 2028 registering a CAGR of 10.9%, according to a new report by Grand View Research, Inc. High adoption and demand for early non-invasive prenatal testing (NIPT) coupled with improvements in reimbursement scenario are among the factors driving the market.

The use of invasive techniques of prenatal testing, such as chorionic villus sampling and amniocentesis, can lead to issues, such as miscarriage. This has led to a decline in the use of these procedures and high demand for tests that are more efficient, non-invasive, and safe. Furthermore, non-invasive fetal tests have a lower failure and false-positive rate, which has resulted in a considerable increase in uptake of non-invasive tests in the last few years.

The non-invasive prenatal testing market is highly saturated with the existing key players. Companies are forming partnerships and collaborations to maintain a stable position in the market. For instance, in August 2020, Eurofins Scientific announced an agreement with Noritsu Koki Co., Ltd. for the acquisition of GeneTech Inc., one of the pioneering NIPT developers in Japan. With this acquisition, Eurofins Scientific is set to strengthen its presence in the Japanese NIPT market.

Request a free sample copy or view report summary: Non-invasive Prenatal Testing Market Report

Non-invasive Prenatal Testing Market Report Highlights

The 13-24 weeks gestation period segment accounted for the largest revenue share in 2020 owing to the presence of a maximum number of tests carried out in this phase of pregnancy
NIPT for high- & average-risk pregnancy led the market owing to the presence of favorable payer reimbursement policies in this segment
Next-Generation Sequencing(NGS) is estimated to be the largest as well as the fastest-growing technology segment from 2021 to 2028, as NGS is the most commonly used method for NIPT
The diagnostic laboratories end-use segment held the largest revenue share in 2020 and will expand further at the fastest CAGR from 2021 to 2028 due to the rising number of diagnostic laboratories across the globe that offer NIPT
Asia Pacific is expected to register the fastest year-on-year growth owing to the gradually increasing average maternal age and rising incidence of chromosomal aneuploidies
One of the key trends followed by market participants includes licensing of the test to other labs and generating significant revenue by collecting royalty payments

Non-invasive Prenatal Testing Market Segmentation

Grand View Research has segmented the global non-invasive prenatal testing market on the basis of the gestation period, risk type, method, technology, product, end-use, and region:

NIPT Gestation Period Outlook (Revenue, USD Million, 2017 - 2028)

0-12 Weeks
13-24 Weeks
25-36 Weeks

NIPT Risk Type Outlook (Revenue, USD Million, 2017 - 2028)

High & Average Risk
Low Risk

NIPT Method Outlook (Revenue, USD Million, 2017 - 2028)

Ultrasound Detection
Biochemical Screening Tests
Cell-Free DNA in Maternal Plasma Tests

NIPT Technology Outlook (Revenue, USD Million, 2017 - 2028)

NGS
Array Technology
PCR
Other Technologies

NIPT Product Outlook (Revenue, USD Million, 2017 - 2028)

Consumables & Reagents
Instruments

NIPT End-use Outlook (Revenue, USD Million, 2017 - 2028)

Hospitals & Clinics
Diagnostic Laboratories

NIPT Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
- Singapore
- Australia
Latin America
- Brazil
- Mexico
MEA
- South Africa
- Saudi Arabia

List of Key Players of Non-invasive Prenatal Testing Market

Genesis Genetics (CooperSurgical, Inc.)
Natera, Inc.
Centogene N.V.
Illumina, Inc. (Verinata Health, Inc.)
Eurofins LifeCodexx GmbH
MedGenome Labs Ltd.
Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)
Progenity, Inc.
Qiagen
Laboratory Corp. of America Holdings
Quest Diagnostics, Inc.

About Grand View Research

DNA & RNA Banking Services Market Is Expected To Accomplish A Valuation Of Around USD 8.83 Billion By 2027: Grand View Research Inc.

DNA & RNA Banking Services Market Growth & Trends

The global DNA and RNA banking services market size is expected to reach USD 8.83 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.46% from 2021 to 2027. Biospecimens such as DNA and RNA are critical for biomarker discovery, thereby providing a path for the expansion of personalized medicine. Moreover, progress in translational and clinical research through an introduction of advanced, standardized cell isolation methodologies reduces hands-on-time. The development of automated solutions and the transformation of biobanks into fully automated biobanks potentially accelerate the growth of the market.

A rise in the enrollment of individuals for personalized medicine initiatives drives the revenue generation for DNA and RNA banking services. In July 2019, Partners HealthCare, U.S. enrolled more than 100,000 individuals in its precision medicine biobank that supported clinicians and researchers of the Brigham and Women’s Hospital, U.S., and other partners. Such initiative assisted in examining the impact of several factors on disease and health.

The distribution network is continuously becoming complex, with pharmaceutical firms facing new challenges related to sustainability initiatives, regulatory adherence, and competing priorities cost pressures. The efforts undertaken by the key players to invest in the cold chain storage and expansion of distribution capability in various geographies have increased the capability to handle large quantities of complex cold chain biologics. Key companies such as EasyDNA, DNA Genotek, 23andMe, GoodCell, ProteoGenex., and US Biolab have adopted several strategic alliances to reinforce their market presence.

Request a free sample copy or view report summary: DNA & RNA Banking Services Market Report

DNA & RNA Banking Services Market Report Highlights

By service type, storage services accounted for the largest revenue share in 2020 owing to the presence of numerous key providers in the market space. The advent of automated sample storage systems and automated liquid handlers to manage large sample volume, and reduce the amount of time required to process, store, and distribute samples further drives the segment
Based on specimen type, the blood segment dominated the market in 2020 owing to fast and quick procedures of collecting blood, minimal risk of contamination, and visibility of blood samples
In terms of application, the drug discovery and clinical research segment held the largest share in 2020. Biobanking services are utilized to accelerate the discovery of new therapeutics and offer resources for future investigations to better understand the effects of environmental, genetic, and lifestyle factors on human health, morbidity, and mortality. This factor led to the maximum revenue share of the segment
On the basis of end use, the hospitals and diagnostic centers segment is projected to witness the fastest growth throughout the forecast period owing to the efforts undertaken by government bodies and biobanks to broaden the accessibility for DNA and RNA samples in the hospitals and diagnostic centers for COVID-19 diagnosis
North America accounted for the largest revenue share in 2020. One of the major factors positively accelerating market growth is the initiation of national precision-medicine initiatives, such as the “All of Us” biobank in the U.S.

DNA & RNA Banking Services Market Segmentation

Grand View Research has segmented the global DNA and RNA banking services market on the basis of service type, specimen type, application, end-use, and region:

DNA & RNA Banking Service Type Outlook (Revenue, USD Million, 2016 - 2027)

Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others

DNA & RNA Banking Services Specimen Type Outlook (Revenue, USD Million, 2016 - 2027)

Blood
Buccal Swabs & Hair Follicles
Others

DNA & RNA Banking Services Application Outlook (Revenue, USD Million, 2016 - 2027)

Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Other Applications

DNA & RNA Banking Services End-use Outlook (Revenue, USD Million, 2016 - 2027)

Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others

DNA & RNA Banking Services Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Italy
- Spain
Asia Pacific
- China
- Japan
- India
Latin America
- Brazil
- Mexico
Middle East Africa (MEA)
- South Africa
- Saudi Arabia

List of Key Players of DNA & RNA Banking Services Market

EasyDNA
DNA Genotek Inc.
23andMe, Inc.
GoodCell
US Biolab Corporation, Inc.
Infinity Biologix
Thermo Fisher Scientific, Inc.
deCODE genetics
Brooks Life Sciences
LGC Biosearch Technologies
PreventionGenetics

About Grand View Research

Biopharmaceuticals Contract Manufacturing Market is Estimated to Register at a CAGR of 5.7% During The Forecast Period

Biopharmaceuticals Contract Manufacturing Market Growth & Trends

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7%, according to a new report by Grand View Research, Inc. Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs). Contract manufacturers are engaged in broadening their service portfolio to meet the company demands with respect to regulatory standards and new services.

The reliance of companies on CMOs for the production of biologics and biosimilars is expected to rise over the forecast period as a consequence of changes adopted by the CMOs. This is evident through growing investment in collaborations of companies with CMOs as well as continuous efforts taken up for expanding the service portfolio.

The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst. Also, biopharmaceutical contract manufacturers are observing increased demand related to the Covid-19 vaccine and therapeutics. Thus, the future holds numerous opportunities for the global market. For instance, in 2020, AstraZeneca and Oxford Biomedica signed a one-year clinical and commercial supply agreement for the manufacturing of AstraZeneca’s Covid-19 vaccine candidate, AZD1222.

The future growth of CMOs is highly dependent on the promising opportunities offered by the biopharmaceutical industry, the bioprocessing industry, and the contract service industry. Expansion of fill-and-finish services and increasing robustness of venture capital investments for the life science sector are two important opportunities that are anticipated to drive the market. For instance, in 2019, Shanghai HaiHe Biopharma Co. Ltd. raised USD 146.6 million as venture capital for its large cancer drug portfolio, which they shall utilize along with their outsourcing partner Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Request a free sample copy or view report summary: Biopharmaceuticals Contract Manufacturing Market Report

Biopharmaceuticals Contract Manufacturing Market Report Highlights

Mammalian-based biopharmaceutical contract manufacturing captured the largest market share of over 59% in 2020 owing to the high penetration of mammalian expression system for biologics development
Out of all the services offered in this market, process development contributed to the largest share in 2020 owing to high capital investment, especially in the downstream process
The complexities associated with regulatory approval and good manufacturing practice pronounces the demand for the established contract manufacturers to ensure compliance with regulatory standards
The biologics contract manufacturing segment dominated the global market in 2020 owing to higher demand for biologics production
However, the biosimilar segment is estimated to register the fastest CAGR from 2021 to 2028 due to cost-saving advantages associated with biosimilars development
North America was the dominant regional market in 2020 due to the presence of an effective regulatory framework for biologics development in the U.S.
However, Asia Pacific is expected to emerge as the fastest-growing regional market from 2021 to 2028 owing to emerging countries, such as India and China, incorporating developments to sustain the competition
Several international companies are seeking outsourcing of biopharmaceutical production to Asian countries owing to the continuous expansion of Asian CMOs that offer services at a less price, as compared to the service providers based in western countries

Biopharmaceuticals Contract Manufacturing Market Segmentation

Grand View Research has segmented the global biopharmaceuticals contract manufacturing market on the basis of source, service, product, and region:

Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2016 - 2028)

Mammalian
Non-mammalian

Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2016 - 2028)

Process Development
- Downstream
- Upstream
Fill & Finish Operations
Analytical & QC Studies
Packaging

Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2016 - 2028)

Biologics
- Monoclonal Antibodies (MABs)
- Recombinant Proteins
- Vaccines
- Antisense, RNAi, & Molecular Therapy
- Others
Biosimilars

Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- Germany
- France
Asia Pacific
- China
- India
Latin America
- Brazil
Middle East & Africa
- South Africa

List of Key Players in Biopharmaceuticals Contract Manufacturing Market

Boehringer Ingelheim GmbH
Lonza
Inno Biologics Sdn Bhd
Rentschler Biotechnologie GmbH
JRS Pharma
AGC Biologics
ProBioGen
Fujifilm Diosynth Biotechnologies U.S.A., Inc.
Toyobo Co., Ltd.
Samsung BioLogics
Thermo Fisher Scientific, Inc.
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.

About Grand View Research

Sunday, 31 January 2021

3D Bioprinting Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

Inkjet-based
Magnetic Levitation
Syringe-based
Laser-based
Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

Medical
- Tissue and organ generation
- Medical pills
- Prosthetics and implants
Dental
Biosensors
Consumer/Personal Product Testing
Bioinks
Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
Latin America
- Brazil
- Mexico
- Argentina
- Columbia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

List of Key Players of 3D Bioprinting Market

Envisiontec, Inc.
Organovo Holdings, Inc.
Inventia Life Science PTY LTD
Poietis
Vivax Bio, LLC
Allevi
Cyfuse Biomedical K.K.
3D Bioprinting Solutions
Cellink Global
Regemat 3D S.L.

About Grand View Research

Impact of Existing and Emerging Bottled Water Market Trends And Forecast 2021-2028: Grand View Research Inc.

Bottled Water Market Growth & Trends

The global bottled water market size is expected to reach USD 505.19 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.1% from 2021 to 2028. The growing awareness regarding the adverse health effects of consuming sugary drinks, such as weight gain, obesity, diabetes, and heart disease, is supporting the consumption of alternative beverages, such as still and sparkling water.

The growth of the market is primarily attributed to rising awareness regarding the importance of hydration. According to a study conducted by the International Bottled Water Association in 2018, it was revealed that 93% of American citizens want bottled water to be sold in most stores selling beverages. A substantial part of the population prefers to quench their thirst using bottled water over other beverages.

Increasing preference for nutrient-fortified water is trending owing to the rising importance of health and wellness among buyers. The water demand has been increasing among travelers, working professionals, and for use in households.

COVID-19 has impacted the market for bottled water as many quick-service restaurants have been witnessing a significant drop in their sales. For instance, according to a blog post by CNBC LLC, McDonald’s had witnessed a decline of 22% in March compared to the previous month. COVID-19 compelled the company to shut down its dining rooms.

Request a free sample copy or view report summary: Bottled Water Market Report

Bottled Water Market Report Highlights

The inclination toward packaged water rather than ordinary water, particularly among younger consumers, drives product sales. Observing this trend, several restaurants are providing bottled water to meet consumer demand
The purified water segment held the largest share of more than 35.0% in 2020. According to a United Nations study published in 2018, there are almost 16,000 desalination plants across 177 countries that provide purified water
The sparkling water segment is anticipated to be the fastest-growing segment with a CAGR of 11.7% from 2021 to 2028. Sparkling water is also marketed as sparkling drinking water or sparkling mineral water. Water that contains the same amount of carbon dioxide as its source post-treatment is defined as sparkling water
Asia Pacific held the largest market share in 2020 and is expected to maintain its lead throughout the forecast period. The regional market is mainly driven by the growing preference for bottled water owing to rising health issues caused by the consumption of contaminated water in countries, including China and India

Bottled Water Market Segmentation

Grand View Research has segmented the global bottled water market on the basis of product and region:

Bottled Water Product Outlook (Revenue, USD Million, 2016 - 2028)

Spring
Purified
Mineral
Distilled
Sparkling
Others

Bottled Water Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
Europe
- Germany
- France
Asia Pacific
- China
- India
Central & South America
- Brazil
Middle East & Africa
- South Africa

List of Key Players of Bottled Water Market

Nestlé SA
PepsiCo
The Coca-Cola Company
DANONE
Primo Water Corporation
FIJI Water Company LLC.
Gerolsteiner Brunnen GmbH & Co. KG
VOSS WATER
Nongfu Spring
Rhodius Mineralquellen Und Getranke GmbH & Co KG

About Grand View Research

North America Digital Pathology Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

North America Digital Pathology Market Growth & Trends

The North America digital pathology market size is expected to reach USD 593.9 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company's IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

Request a free sample copy or view report summary: North America Digital Pathology Market Report

North America Digital Pathology Market Report Highlights

The software segment is anticipated to witness a lucrative growth rate of 6.8% in the coming years. The segment is inclusive of pathology workflow management solution and LIMS software
This software is simple to install and use, easy to obtain specific patient information, and efficiently and quickly sends reports digitally to pathologists and clinicians. Owing to these associated advantages the software segment is expected to witness lucrative growth over the forecast period
The practice of sharing digital imagery across labs helps in accelerating drug discovery and development processes by enabling pathologists to effectively analyze records and communicate and collaborate on crucial result findings in tissue-based efficacy studies
The disease diagnosis segment is projected to witness a significant CAGR of 7.0% in the coming years as the FDA approved the practice of sharing digital imagery across labs for primary diagnosis applications such as cancer cell detection
Diagnostic laboratories are expected to witness lucrative growth of 7.1% over the forecast period owing to the rising incidence of cancer in this region. Moreover, the implementation of digital pathology solutions and devices is likely to help improve laboratory workflow efficiency, accuracy, and quality of disease diagnosis using computational pathology
Competitive rivalry in the market is expected to remain high over the forecast period. The market is dominated by few players such as Philips and Leica Biosystems that hold a majority of the revenue
The strategies implemented by these players are product differentiation, new product launch, collaboration, merger, and acquisition to gain a larger share of the market

North America Digital Pathology Market Segmentation

Grand View Research has segmented the North America digital pathology market on the basis of the product, application, end use, and country:

North America Digital Pathology Product Outlook (Revenue, USD Million, 2016 - 2028)

Software
Device

North America Digital Pathology Application Outlook (Revenue, USD Million, 2016 - 2028)

Drug Discovery & Development
Academic Research
Disease Diagnosis
- Cancer Cell Detection
- Others

North America Digital Pathology End-use Outlook (Revenue, USD Million, 2016 - 2028)

Cancer Hospitals
Diagnostic Labs
Academic & Research Institutes

North America Digital Pathology Country Outlook (Revenue, USD Million, 2016 - 2028)

US.
Canada

List of Key Players of North America Digital Pathology Market

Leica Biosystems
Hamamatsu Photonics, Inc.
Koninklijke Philips N.V.
Hoffmann-La Roche Ltd
Mikroscan Technologies
3DHISTECH Ltd.
Inspirata, Inc.
Visiopharm A/S
Huron Technologies International, Inc.
Sectra AB

About Grand View Research

Healthcare Contract Manufacturing Market Strong Application and Emerging Trends also Scope by 2028: Grand View Research Inc.

Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is expected to reach USD 323.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.7% from 2021 to 2028. The changing regulatory landscape, coupled with rising offshoring to emerging countries, is anticipated to propel the market growth over the forecast period.

Increasing demand for advanced products is a major factor driving the market. Original equipment manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly to developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions, such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Moreover, the growing geriatric population across the globe and the consequent rise in age-related diseases have stimulated the progress of pharmaceutical and medical device development, thus leading to the growth of the healthcare manufacturing industry. With a rise in demand, the market now witnesses an influx of manufacturing service providers. Asia Pacific was the dominant regional market for medical device outsourcing in 2020 owing to lower cost and easy availability of skilled human resources. For instance, according to IBEF, M&A deals in the healthcare sector in India increased by 155% (USD 1.09 billion) in 2019.

A rise in the number of medical device companies vying to enter regional markets, such as India and China, is further expected to contribute to the growth of this market. For instance, the Chinese government’s Marketing Authorization Holder (MAH) scheme facilitates international healthcare players to produce their products within the local Chinese market equipped with state-of-the-art centers. The expansion of production capacity by players such as WuxiBiologics is a distinguished example of this deliberate plan.

Due to the emergence of infections, such as COVD-19, many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on a large scale. Hence, we can say that the pandemic has had a positive impact on this industry.

This paradigm shift from in-house manufacturing to contract manufacturing in the pharmaceutical and medical device industry has resulted in the increased focus of the companies on contract manufacturing service vendors. These services have effectively addressed the concerns regarding pharmaceutical and medical device manufacturing as well as significantly accelerated the commercialization of products.

Request a free sample copy or view report summary: Healthcare Contract Manufacturing Market Report

Healthcare Contract Manufacturing Market Report Highlights

By type, the pharmaceutical segment dominated the market with a share of 75.2% in 2020 owing to low manufacturing budget and highly sophisticated contract manufacturing service offerings
The medical device type segment is expected to be the fastest-growing segment with a CAGR of 9.7% over the forecast period owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
Cardiology was the dominant therapeutic area segment in the medical device contract manufacturing market in 2020 owing to rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
Asia Pacific dominated the market in 2020 and is expected to witness the fastest growth over the forecast period owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region

Healthcare Contract Manufacturing Market Segmentation

Grand View Research has segmented the global healthcare contract manufacturing market based on type and region:

Healthcare Contract Manufacturing Type Outlook (Revenue, USD Billion, 2016 - 2028)

Medical Device
- By Service
  - Accessories Manufacturing
  - Assembly Manufacturing
  - Component Manufacturing
  - Device Manufacturing
- By Therapeutic Area
  - Cardiology
  - Diagnostic Imaging
  - Orthopedic
  - IVD
  - Ophthalmic
  - General & Plastic Surgery
  - Drug Delivery
  - Dental
  - Endoscopy
  - Diabetes Care
  - Others
- Pharmaceutical
  - By Service
    - API/Bulk Drugs
    - Advanced Drug Delivery Formulations
    - Packaging
    - Finished Dose Formulations
      - Solid
      - Liquid
      - Semi-solid Formulations

Healthcare Contract Manufacturing Regional Outlook (Revenue, USD Billion, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
- Russia
- Belgium
- Netherlands
- Switzerland
- Sweden
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Indonesia
- Malaysia
- Singapore
- Thailand
- Taiwan
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Israel

List of Key Players of Healthcare Contract Manufacturing Market

Nordson Corporation
Integer Holdings Corporation
Jabil Inc.
Viant Technology LLC
FLEX LTD.
Celestica Inc.
Sanmina Corporation
Plexus Corp.
Phillips-Medisize
Synecco
Catalent, Inc.

About Grand View Research

Biobanks Market To Hold a High Potential for Growth by 2028: Grand View Research Inc.

Biobanks Market Growth & Trends

The global biobanks market size is expected to reach USD 106.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Biobanks continue to evolve with the introduction of new technologies such as NGS and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market.

The quality of biospecimens can significantly influence the disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples. For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples.

This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

Request a free sample copy or view report summary: Biobanks Market Report

Biobanks Market Report Highlights

The biobanking equipment segment accounted for the maximum revenue share in 2020 owing to the high cost of instruments coupled with an increase in the number of biorepositories
The biobanking and repository services segment accounted for the largest revenue share of 36.0% in the market
This is because of the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicineand disease-specific research
Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
The virtual biobanks segment is anticipated to witness the fastest growth rate over the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
The therapeutics application segment accounted for the largest revenue share in 2020 owing to the growing popularity of cell therapies for cancer treatment
Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment
North America dominated the market with its wide network of centers for biosample storage in the U.S.
Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving the revenue in North America
In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across the Asian countries
The key players are engaged in expanding their global reach by partnering with global distributors, merger, and acquisition of other players, and entering a strategic alliance with research communities

Biobanks Market Segmentation

Grand View Research has segmented the global biobanks market on the basis of product, service, biospecimen type, biobanks type, application, and region:

Biobanks Product Outlook (Revenue, USD Million, 2017 - 2028)

Biobanking Equipment
- Temperature Control Systems
  - Freezers & Refrigerators
  - Cryogenic Storage Systems
  - Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems

Biobanks Service Outlook (Revenue, USD Million, 2017 - 2028)

Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Services

Biobanks Biospecimen Type Outlook (Revenue, USD Million, 2017 - 2028)

Human Tissues
Organs
Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
Other Biospecimens

Biobanks Type Outlook (Revenue, USD Million, 2017 - 2028)

Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
Virtual Biobanks

Biobanks Application Outlook (Revenue, USD Million, 2017 - 2028)

Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Other Applications

Biobanks Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Spain
- Italy
Asia Pacific
- Japan
- China
- India
- Australia
- Singapore
Latin America
- Brazil
Middle East & Africa
- South Africa

List of Key Players of Biobanks Market

Thermo Fisher Scientific, Inc.
Merck KGaA
QIAGEN
Hamilton Company
Avantor
Tecan Trading AG.
Danaher Corporation
Becton, Dickinson and Company (BD)
BioCision
Taylor-Wharton
Charles River Laboratories
Lonza
STEMCELL Technologies Inc.
Biovault Family
PromoCell GmbH
Precision Cellular Storage Ltd. (Virgin Health Bank)

About Grand View Research

Friday, 29 January 2021

3D Cell Culture Market to Bring In USD 3.48 Billion by End of the Forecast Period

3D Cell Culture Market Growth & Trends

The global 3D cell culture market size is expected to reach USD 3.48 billion by 2028 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. The development of 3D optimized assays, kits, and protocols coupled with the evolution of assay techniques is anticipated to drive the three-dimensional cell culture market.

As 3-dimensional cultures have the capacity to closely mimic a typical morphology and microarchitecture of organs, these are continuously developed for the studies that require in vivo model systems to analyze the effect of a foreign drug over body tissues and organs. This, coupled with the availability of various choices in terms of material and structure of the scaffold for different in vitro applications, is anticipated to support revenue generation for scaffolds.

Recent researches have explored the use of a diverse range of scaffolds including graphene scaffolds, nanofibers, freeze-casting, natural marine collagen, and others. In addition, the application of lab-on-a-chip techniques in several assay types-proliferation, viability, stimulation, transport, patch clamping, high content screening, and metabolic activity-leads to a rise in demand for projects with advanced and efficient solutions.

Request a free sample copy or view report summary: 3D Cell Culture Market Report

3D Cell Culture Market Report Highlights

The scaffold-based technology segment is anticipated to register a lucrative year-on-year growth owing to rising demand for 3D model-based research coupled with an increased incidence of chronic diseases
Moreover, the introduction of novel tools and techniques is anticipated to boost revenue generation in the scaffold-based technology segment
Furthermore, companies, such as Tecan and Sigma-Aldrich, offer scaffold-based 3D solutions; which are readily adopted by the end users
Cancer was the largest application segment of the market in 2020. This is because 3D cultures efficiently replicate the associated influences and complexity of in vivo tumor microenvironment including the impact of extracellular matrix and cell-to-cell contact
Cells in 3-dimensional cultures help in the analysis of behavior and properties of the tumor, protein distribution, gene expression, and monitor response to anticancer therapies
Potential scientific and clinical impacts of the 3D-cultivation approach for embryonic, adult, and cancer stem cells are estimated to boost the growth of the stem cell research segment
Biotechnology and pharmaceutical organizations accounted for the largest share in 2020 owing to a rise in the adoption of 3D cell culture techniques in tissue engineering and drug discovery
Combination of 3D cell culture techniques with Human-induced Pluripotent Stem Cells (HiPSCs) has been successfully used for the development and discovery of drugs for liver diseases
North America led the market in 2020 owing to extensive usage of 3D cell culture models for medical research purposes
In April 2020, a team of researchers from the University of Pittsburgh used Multicellular Tumor Spheroids (MCTSs) to assess drug responses in drug screening studies for oncology
Asia Pacific is expected to register the fastest CAGR from 2021 to 2028 due to rising investments by North American and European companies in APAC regional market
The key market players focus on geographical expansions, partnerships, collaborations, acquisitions, and novel product launches to reinforce their market presence
For instance, in December 2020, Curiteva, Inc. acquired FossiLabs, LLC. The latter has developed a process to fabricate scaffolding structures that promote osseointegration

3D Cell Culture Market Segmentation

Grand View Research has segmented the global 3D cell culture market on the basis of technology, application, end use, and region:

3D Cell Culture Technology Outlook (Revenue, USD Million, 2016 - 2028)

Scaffold-based
- Hydrogels
- Polymeric Scaffolds
- Micro-patterned Surface Microplates
- Nanofiber-based Scaffolds
Scaffold-free
- Hanging Drop Microplates
- Microfluidic 3D Cell Culture
- Spheroid Microplates with ULA coating
- Magnetic Levitation & 3D Bioprinting
Bioreactors

3D Cell Culture Application Outlook (Revenue, USD Million, 2016 - 2028)

Cancer
Tissue Engineering & Immunohistochemistry
Drug Development
Stem Cell Research
Others

3D Cell Culture End-use Outlook (Revenue, USD Million, 2016 - 2028)

Biotechnology and Pharmaceutical Industries
Research Laboratories and Institutes
Hospitals and Diagnostic Centers
Others

3D Cell Culture Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
Asia Pacific
- Japan
- China
Latin America
- Brazil
MEA
- South Africa

List of Key Players of 3D Cell Culture Market

Merck KGaA
Thermo Fisher Scientific, Inc.
PromoCell GmbH
Greiner Bio One International GmbH
Corning, Inc.
3D Biomatrix
Lonza
Avantor Performance Materials, LLC
Tecan Trading AG
3D Biotek LLC
Global Cell Solutions, Inc.
InSphero

About Grand View Research

Point Of Care Diagnostics & Testing Market is Anticipated to Upgrade USD 35.74 Billion Revenue By 2028

Point Of Care Diagnostics & Testing Market Growth & Trends

The global point of care diagnostics & testing market size is estimated to reach USD 35.74 billion by 2028, registering a CAGR of 3.25%, according to a new report by Grand View Research, Inc. Point of care (POC) diagnostics & testing has significantly altered the therapeutic models applied for the treatment of diabetic patients, HIV patients, and patients with Cardiovascular Disorders (CVDs), in recent years. In addition, emerging advancements on the horizon are projected to enhance the near-patient treatment workflows for infectious diseases, strokes, and cancer.

The industry is set to witness lucrative growth as POC testing serves as a profitable alternative to traditional laboratory tests. Point-of-care devices are designed to offer actionable information at the location and time of patient care, which enables early diagnosis of diseases. The advent of non-invasive & minimally invasive POC devices, continuous POCT, miniaturized technologies, and the adoption of telemedicine in remote patient monitoring are some of the key trends contributing to the market growth.

Moreover, the advent of rapid data sharing solutions as well as platforms is set to contribute to the development of POC COVID-19 tests, supplementing the overall market growth. Companies actively working toward the development of such rapid data sharing solutions include Foundation for Innovative New Diagnostics (FIND) and 360 Dx. The rising number of such companies is set to offer manufacturers/developers and professionals a clear perspective with respect to the future opportunities associated with POC COVID-19 tests.

The development of multiplex POC diagnostic technologies that enable the detection of multiple infectious pathogens in specimens, such as sputum, urine, or blood, offers improved patient outcomes and better disease diagnosis. The wide adoption of multiplex POC devices is anticipated to serve as a driver for the shift in preference from a centralized disease testing model to a decentralized patient-centered model.

Major companies are initiating strategic product launches to strengthen their market presence. For instance, in October 2020, Roche announced the launch of the Elecsys SARS-CoV-2 Antigen test that supports COVID-19 testing of suspected patients at high volumes. In April 2020, Nova Biomedical introduced PT/INR testing for its Allegro capillary blood analyzer to be used in POC primary care settings. This test is available in CE-regulated countries.

PR/INR is among the total 18 tests of the Allegro platform and is designed to measure HbA1c, hemoglobin, cholesterol, glucose, triglycerides, UACR, creatinine, hematocrit, and uric acid. This product expanded the testing portfolio of the company’s Allergo platform.

Request a free sample copy or view report summary: Point Of Care Diagnostics & Testing Market Report

Point of Care Diagnostics & Testing Market Report Highlights

The glucose testing product segment led the market in 2020 due to high demand for POC glucose monitors for routine glucose testing as a result of an increased number of diabetic patients across the globe
The infectious disease product segment is expected to account for the highest revenue share by 2028. This growth is majorly attributed to the global COVID-19 pandemic
The first POC diagnostic test for COVID-19 was approved by the U.S. FDA in March 2020 under Emergency Use Authorization, which was manufactured by Cepheid
Since then, key players in this market are engaged in developing and manufacturing such tests, which, in turn, is boosting the segment growth
The clinics end-use segment accounted for the dominant revenue share in 2020 and will expand further at a steady CAGR from 2021 to 2028 owing to increasing transition from conventional lab testing to POCT by healthcare professionals to shorten the time taken for diagnosis and further treatments
Led by the U.S., North America was the leading regional market in 2020 and held a revenue share of more than 34%

Point Of Care Diagnostics & Testing Market Segmentation

Grand View Research has segmented the global point of care diagnostics & testing market on the basis of product, end-use, and region:

POC Diagnostics & Testing Product Outlook (Revenue, USD Million, 2017 - 2028)

Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
- HIV
- Clostridium Difficile
- HBV
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV)
- HPV
- Influenza/Flu
- HCV
- MRSA
- TB and Drug-Resistant TB
- HSV
- COVID-19
- Other Infectious Diseases
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug Abuse Testing
Urinalysis

POC Diagnostics & Testing End-use Outlook (Revenue, USD Million, 2017 - 2028)

Clinics
- Pharmacy & Retail Clinics
- Physician Office
- Urgent Care Clinics
- Non-practice Clinics
Hospitals
Home
Assisted Living Healthcare Facilities
Laboratory

POC Diagnostics & Testing Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America
- US.
- Canada
Europe
- Germany
- UK.
- France
- Italy
- Spain
- Russia
Asia Pacific
- Japan
- China
- India
- Australia
- Korea
Latin America
- Brazil
- Mexico
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia

List of Key Players of POC Diagnostics & Testing Market

Hoffmann-La Roche Ltd.
Qiagen
Danaher Corp.
Becton Dickinson (BD)
Biomerieux SA
Abbott Laboratories
Siemens Healthcare AG
Zoetis, Inc.
Instrumentation Laboratory
Nova Biomedical
Trividia Health, Inc.
Quidel Corp.
Trinity Biotech
Sekisui Diagnostics
Orasure Technologies, Inc.
Nipro Corp.
Spectral Medical, Inc.

About Grand View Research

Product Design & Development Services Market Current And Future Market Conditions 2021-2028: Grand View Research Inc.

Product Design And Development Services Market Growth & Trends

The global product design and development services market size is expected to reach USD 18.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. Low product cost, short time-to-market, and demand for advanced technologies are some of the factors boosting the growth. Medical and life sciences companies face extreme cost pressures to develop new and innovative products in shorter time frames while complying with stringent regulatory requirements of medical device.

The manufacturers face more hurdles in getting cost-effective high-quality products to market faster along with some internal factors, such as designing and production. Hence, medical device companies adopt a design-to-manufacturing approach where design, engineering, as well as production teams work in collaboration to develop the product model. This approach enhances both product quality and profitability by decreasing errors in development and designing thereby increasing success rates.

Outsourcing design engineering is anticipated to witness healthy growth over the forecast period as an increased number of manufacturers—from start-up ventures to established companies—capitalize on the benefits related to outsourcing design engineering such as improved product design and cost-effectiveness to attain a competitive edge. Furthermore, with the incorporation of IT into healthcare industry, analysis on 3D models and software, for which the third parties are well trained are expected to promote growth.

However, COVID-19 has added complexity and challenge to the medical device innovation. The product development firms are facing the major challenges so far as how to continue with business operations while evading the effects of the crisis. Product development during the pandemic continues to show optimal scope. The huge cost of development, financial risks of missing the mark, and market timing altogether contribute to the greatest challenges of medical device development and market driving innovation.

Request a free sample copy or view report summary: Product Design And Development Services Market Report

Product Design & Development Services Market Report Highlights

The research, strategy, and concept generation services segment accounted for the highest revenue share of 39.9% in 2020 as the stage requires extensive research and business and design strategy that generate maximum revenue
The surgical instruments segment held major market share of 27.9% in 2020, due to the complexity of instruments which require detailed designing for making them suitable for direct contact with human body
Key players in emerging economies of Asia Pacific and Latin America are witnessing significant increase in their revenue owing to the presence of lucrative growth opportunities
Medical device Original Equipment Manufacturers (OEMs) are outsourcing the production of their devices to developing economies due to availability of labor and raw materials at affordable cost

Product Design & Development Services Market Segmentation

Grand View Research has segmented the global product design and development services market based on services, application, end use, and region:

Product Design And Development Services Outlook (Revenue, USD Million, 2016 - 2028)

Research, Strategy, & Concept Generation
Concept & Requirements Development
Detailed Design & Process Development
Design Verification
Process Validation, Manufacturing Transfer & Design Validation
Production & Commercial Support

Product Design And Development Services Application Outlook (Revenue, USD Million, 2016 - 2028)

Diagnostic Equipment
Therapeutic Equipment
Surgical Instruments
Clinical Laboratory Equipment
Biological Storage
Consumables
Others

Product Design And Development Services End-use Outlook (Revenue, USD Million, 2016 - 2028)

Medical Device Companies
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations

Product Design And Development Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
- Russia
- Ukraine
- Netherlands
- Switzerland
- Sweden
Asia Pacific
- India
- Japan
- China
- Australia
- South KoreaIndonesia
- Malaysia
- Singapore
- Thailand
- Taiwan
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt

List of Key Players of Product Design And Development Services Market

Ximedica
DeviceLab Inc.
Jabil Inc.
Flex Ltd.
Plexus Corp.
Celestica Inc.
Starfish Medical
Nordson Medical
Planet Innovation
Donatelle

About Grand View Research

Transplantation Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 26.5 billion by 2028, growing at a CAGR of 11.5%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in high demand for transplantation procedures, which is boosting the market growth. Rising demand for transplant products, such as tissue products, immunosuppressants, and organ preservation solutions, is also a major factor driving the market. Many biotechnology and medical device companies are concentrating on the development of advanced transplant products for the management of organ failure.

Thus, technological advancement and the development of novel & improved transplant products, such as surgical instruments, have majorly contributed to the expansion of the market. In addition, the introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane, provides higher benefits during treatment. Furthermore, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports market growth.

Request a free sample copy or view report summary: Transplantation Market Report

Transplantation Market Report Highlights

The tissue products segment accounted for the largest revenue share in 2020 due to increased demand for tissue and organ transplant procedures
The tissue products segment is expected to expand further at a significant CAGR from 2021 to 2028 owing to the advancements in transplantation products
The tissue transplant segment held the largest revenue share in 2020 on account of the high demand for tissue transplant procedures worldwide
The transplant centers segment is projected to record the fastest CAGR during the forecast period owing to the rising popularity of these centers for transplant procedures
The hospitals segment dominated the market, in terms of revenue share, in 2020 owing to a large number of transplant procedures performed in hospitals
North America was the leading regional market in 2020 and is projected to maintain its dominance during the forecast period owing to the presence of well-developed healthcare infrastructure in the region
The presence of a large number of research laboratories, biotechnology, and medical device companies inNorth America is also one of the key factors contributing to the region’s growth

Transplantation Market Segmentation

Grand View Research has segmented the global transplantation market on the basis of product type, application type, end-use, and region:

Transplantation Product Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

Tissue Products
Immunosuppressive Drugs
Preservation Solutions

Transplantation Application Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

Organ Transplant
Tissue Transplant

Transplantation End-use Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

Hospitals
Transplant Centers
Others

Transplantation Regional Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
Latin America
- Brazil
- Mexico
MEA
- South Africa
- Saudi Arabia

List of Key Players of Transplantation Market

Stryker Corp.
Medtronic PLC
AbbVie Inc.
Zimmer Biomet
Novartis International AG
21st Century Medicine
Biolife Solutions
Teva Pharmaceutical
Veloxis Pharmaceuticals

About Grand View Research

Sex Toys Market to Reach Around $52.39 Billion by 2028: Grand View Research Inc.

Sex Toys Market Growth & Trends

The global sex toys market size is expected to reach USD 52.39 billion by 2028, based on a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.04% during the forecast period. Women aging from 16 to 70 years old are indulging in the pleasure of adult toys. The stigma of using these products to replace a partner has long been broken by couples who enjoy these toys from time to time, which is expected to drive the market growth.

The impact of the COVID-19 pandemic is expected to create an economic downturn in all industries as the majority of countries are in lockdown. However, the initial impact of country-wide lockdown has exhibited a boost in sales of sex toys. Several countries such as Italy, the U.S., Australia, U.K., Canada, and France reported high demand for sex toys, from January to March 2020. These countries have also experienced increased sales, from the anticipated yearly forecast. People are advised to practice social distancing and self-isolation for self-care, which has led to an increase in the sales of sex toys such as vibrators and massagers.LELO launched a wave of Stayhome and Save deals applicable for the entire month of May 2020, wherein the company was offering up to 15% discounts on its products.

Asia Pacific is expected to be the fastest-growing market during the forecast period. China and Australia are the leading revenue generators in the market. The stigma surrounding sex is reducing among millennials and Gen-Z, who are more open to exploring new things to enhance their sexual experience.In March 2019, Reckitt Benckiser launched its direct-to-consumer e-commerce platform to sell its premium products in India.

Request a free sample copy or view report summary: Sex Toys Market Report

Sex Toys Market Report Highlights

The female sex toys segment held the largest market share in 2020 and is expected to expand at the second-highest CAGR during the forecast period. Single women are among the leading contributors to the market growth
Manufacturers are trying to reach a larger market via e-commerce sites. In developing countries where adult stores are not easily accessible, online retailers are meeting customer demand by offering a different range of products via discrete delivery and an added advantage of discounted rates
North America held the largest market share in 2020, owing to the presence of numerous retailers providing easy access to products. In the U.S. and Canada, sociodemographic factors also play a role in the type of toy being preferred and its frequency of use
With increasing disposable income in developing countries, consumers are opting for innovative products such as exquisite vibrators, BDSM gear, and anal toys. This increases opportunities for market players to capitalize on the growing demand for more high-end innovative products
Emerging players backed by technological advancements are developing products that offer a more realistic experience. Brand leaders such as Doc Johnson, LELO, FleshLight, and LoveHoney have a global presence with a strong product portfolio.In July 2019, LifeStyles Healthcare announced the launch of three new intimate accessories under its SKYN brand-SKYN Thrill, SKYN Vibes, and SKYN Shiver

Sex Toys Market Segmentation

Grand View Research has segmented the global sex toys market based on type, distribution channel, and region:

Sex Toys Type Outlook (Revenue, USD Million, 2016 - 2028)

Female
Male

Sex Toys Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

E-commerce
Specialty Stores
Mass Merchandizers

Sex Toys Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
Asia Pacific
- China
- Australia
- Japan
- India
Latin America
- Brazil
- Mexico
Middle East & Africa
- South Africa

List of Key Players of the Sex Toys Market

Church & Dwight Co., Inc.
Reckitt Benckiser Group plc
LELO
LifeStyles Healthcare Pte Ltd
Doc Johnson Enterprises
Lovehoney Group Ltd
BMS Factory
PinkCherry
Tenga Co., Ltd.
Fun Factory
We-Vibe

About Grand View Research

Thursday, 28 January 2021

Craniomaxillofacial Devices Market Trends Regulations And Competitive Landscape Outlook to 2028

Craniomaxillofacial Devices Market Growth & Trends

The global craniomaxillofacial devices market size is expected to reach USD 3.2 billion by 2028 registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Craniofacial surgery treats conditions that affect the head, skull, face, and neck. The rise in the number of facial and head injuries caused due to road accidents and increasing cases of sports-related injuries are expected to boost demand for craniomaxillofacial (CMF) devices.

Growingpreferencefor minimally invasive surgeries is also one of the key factors expected to support market growth. Organizations, such as the American Society of Craniofacial Surgery (ASCFS) and the International Society of Craniofacial Surgery (ISCFS), are conducting a research program in a probe to increase awareness of CMF surgeries, boosting consumer awareness about the craniomaxillofacial devices. This is also projected to help boost the overall market growth.

Neck injuries are one of the most common types of injuries in vehicle accidents. Over 800, 000 cases of vehicle crashes involving neck injuries are reported per year in the U.S. Moreover, sports injuries, car accidents, and falls were some of the leading causes of head injuries in the country. Hence, the U.S. is expected to be a potential market for CMF device manufacturers. The global pandemic has led to the cancellation and rescheduling of surgical procedures, which will hamper the market growth to some extent.

Request a free sample copy or view report summary: Craniomaxillofacial Devices Market Report

Craniomaxillofacial Devices Market Report Highlights

In 2020, the CMF plate and screw fixation segment led the global market due to the rise in the number of surgeries requiring bone stabilization
The bioabsorbable material segment is estimated to register the fastest CAGR during the forecasted period due to technological advancements
Neurosurgery & ENT is expected to be the fastest-growing application segment from 2021 to 2028 due to an increase in the volume of surgical procedures pertaining to trauma and the adoption of deep brain stimulation procedures
Latin American region is projected to be the fastest-growing regional market during the forecast period on account of rising cases of accidents in Brazil and Mexico

Craniomaxillofacial Devices Market Segmentation

Grand View Research has segmented the global craniomaxillofacial devices market on the basis of product, material, application, and region:

CMF Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

Cranial Flap Fixation
CMF Distraction
Temporomandibular Joint Replacement
Thoracic Fixation
Bone Graft Substitute
CMF Plate & Screw Fixation

CMF Devices Material Outlook (Revenue, USD Million, 2016 - 2028)

Metal
Bioabsorbable Material
Ceramics

CMF Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

Neurosurgery & ENT
Orthognathic & Dental Surgery
Plastic Surgery

CMF Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America
- US.
- Canada
Europe
- UK.
- Germany
- France
- Italy
- Spain
- Russia
Asia Pacific
- Japan
- China
- India
- Australia
- Singapore
- Malaysia
Latin America
- Brazil
- Mexico
MEA
- South Africa
- Saudi Arabia

List of Key Players of Craniomaxillofacial Devices Market

DePuy Synthes (J&J)
Stryker Corp.
Medtronic plc
Zimmer Biomet

About Grand View Research

Market Research Size

Wednesday, 3 February 2021

Wearable Medical Devices Market to Expand at a CAGR of 26.8% Through 2028

Monday, 1 February 2021

Non-invasive Prenatal Testing Market Outlook, Leading Manufacturers, Industry Analysis And Forecast

DNA & RNA Banking Services Market Is Expected To Accomplish A Valuation Of Around USD 8.83 Billion By 2027: Grand View Research Inc.

Biopharmaceuticals Contract Manufacturing Market is Estimated to Register at a CAGR of 5.7% During The Forecast Period

Biopharmaceuticals Contract Manufacturing Market Growth & Trends

Biopharmaceuticals Contract Manufacturing Market Report Highlights

Biopharmaceuticals Contract Manufacturing Market Segmentation

Sunday, 31 January 2021

3D Bioprinting Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

Impact of Existing and Emerging Bottled Water Market Trends And Forecast 2021-2028: Grand View Research Inc.

North America Digital Pathology Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

Healthcare Contract Manufacturing Market Strong Application and Emerging Trends also Scope by 2028: Grand View Research Inc.

Biobanks Market To Hold a High Potential for Growth by 2028: Grand View Research Inc.

Friday, 29 January 2021

3D Cell Culture Market to Bring In USD 3.48 Billion by End of the Forecast Period

Point Of Care Diagnostics & Testing Market is Anticipated to Upgrade USD 35.74 Billion Revenue By 2028

Product Design & Development Services Market Current And Future Market Conditions 2021-2028: Grand View Research Inc.

Transplantation Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

Sex Toys Market to Reach Around $52.39 Billion by 2028: Grand View Research Inc.

Thursday, 28 January 2021

Craniomaxillofacial Devices Market Trends Regulations And Competitive Landscape Outlook to 2028

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

Search This Blog